A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)
MEYER, Ralf G, BRITTEN, Cedrik M, BERNHARD, Helga, JAKOB, Thilo, HEIN, Rüdiger, SCHULER, Gerold, SCHULER-THURNER, Beatrice, WAGNER, Stephan N, DREXLER, Ingo, SUTTER, Gerd, ARNDTZ, Nathaly, CHAPLIN, Paul, SIEPMANN, Ulrike, METZ, Jost, ENK, Alexander, HUBER, Christoph, WÖLFEL, Thomas, PETZOLD, Barbara, SAGBAN, Tolga A, LEHR, Hans A, WEIGLE, Bernd, SCHMITZ, Marc, MATEO, Luis, SCHMIDT, Burkhard
Published in Cancer Immunology, Immunotherapy (01.05.2005)
Published in Cancer Immunology, Immunotherapy (01.05.2005)
Get full text
Journal Article